Relmada Therapeutics, Inc. (RLMD)

7.155 -0.22 (-2.92%) USD  |  NASDAQ  |  Apr 21, 16:00
7.155 0.00 (0.00%) After-Hours: 18:01
More

Relmada Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Avalo Therapeutics, Inc. Upgrade
AN2 Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade